Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Abnormal Intraepidermal Nerve Fiber Density in Disease: A Scoping Review

View ORCID ProfileSJ Thomas, View ORCID ProfileJ Enders, A Kaiser, L Rovenstine, L Heslop, W Hauser, A Chadwick, DE Wright
doi: https://doi.org/10.1101/2023.02.08.23285644
SJ Thomas
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for SJ Thomas
J Enders
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J Enders
A Kaiser
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Rovenstine
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L Heslop
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W Hauser
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Chadwick
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DE Wright
1Sensory Nerve Disorder Lab, University of Kansas Medical Center, Anesthesiology Department, Kansas City, KS, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dwright{at}kumc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Intraepidermal nerve fiber density (IENFD) has become an important biomarker for neuropathy diagnosis and research. The consequences of reduced IENFD can include sensory dysfunction, pain, and a significant decrease in quality of life. We examined the extent to which IENFD is being used as a tool in human and mouse models and compared the degree of fiber loss between diseases to gain a broader understanding of the existing data collected using this common technique.

Methods We conducted a scoping review of publications that used IENFD as a biomarker in human and non-human research. PubMed was used to identify 1,004 initial articles that were then screened to select articles that met the criteria for inclusion. Criteria were chosen to standardize publications so they could be compared rigorously and included having a control group, measuring IENFD in a distal limb, and using protein gene product 9.5 (PGP9.5).

Results We analyzed 397 articles and collected information related to publication year, the condition studied, and the percent IENFD loss. The analysis revealed that the use of IENFD as a tool has been increasing in both human and non-human research. We found that IENFD loss is prevalent in many diseases, and metabolic or diabetes-related diseases were the most studied conditions in humans and rodents. Our analysis identified 74 human diseases in which IENFD was affected, with 71 reporting IENFD loss and an overall average IENFD change of -47%. We identified 28 mouse and 21 rat conditions, with average IENFD changes of -31.6 % and - 34.7% respectively. Additionally, we present data describing sub-analyses of IENFD loss according to disease characteristics in diabetes and chemotherapy treatments in humans and rodents.

Interpretation Reduced IENFD occurs in a surprising number of human disease conditions. Abnormal IENFD contributes to important complications, including poor cutaneous vascularization, sensory dysfunction, and pain. Our analysis informs future rodent studies so they may better mirror human diseases impacted by reduced IENFD, highlights the breadth of diseases impacted by IENFD loss, and urges exploration of common mechanisms that lead to substantial IENFD loss as a complication in disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by NIH grants RO1 NS043314 (DEW), the Kansas Institutional Development Award (IDeA) P20 GM103418, Kansas University Training Program in Neurological and Rehabilitation Sciences (NIH T32HD057850), and the Translating Obesity, Metabolic Dysfunction, and Comorbid Disease States training program (NIH T32DK128770).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All papers included in our analysis were found on PubMed. A copy of our EndNote library is available upon request.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 08, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Abnormal Intraepidermal Nerve Fiber Density in Disease: A Scoping Review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Abnormal Intraepidermal Nerve Fiber Density in Disease: A Scoping Review
SJ Thomas, J Enders, A Kaiser, L Rovenstine, L Heslop, W Hauser, A Chadwick, DE Wright
medRxiv 2023.02.08.23285644; doi: https://doi.org/10.1101/2023.02.08.23285644
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Abnormal Intraepidermal Nerve Fiber Density in Disease: A Scoping Review
SJ Thomas, J Enders, A Kaiser, L Rovenstine, L Heslop, W Hauser, A Chadwick, DE Wright
medRxiv 2023.02.08.23285644; doi: https://doi.org/10.1101/2023.02.08.23285644

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)